Morgan Stanley Maintains Overweight on enGene Holdings, Maintains $40 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Jeffrey Hung maintains an Overweight rating on enGene Holdings (NASDAQ:ENGN) with a $40 price target.
September 11, 2024 | 3:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley's analyst Jeffrey Hung reaffirms an Overweight rating for enGene Holdings with a $40 price target, indicating confidence in the company's potential.
The reaffirmation of an Overweight rating and a $40 price target by a major analyst like Morgan Stanley suggests a positive outlook for enGene Holdings. This could lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100